Nov 4, 2025 04:21AM
Aug 13, 2025 05:53PM
Aug 5, 2025 05:12AM
Jul 10, 2025 02:25AM
May 29, 2025 07:00AM
May 9, 2025 12:35PM
Mar 4, 2025 04:55AM Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman Sachs
Feb 12, 2025 11:40AM
Nov 13, 2024 05:46AM
Nov 4, 2024 04:15PM
Nov 4, 2024 04:02PM
Nov 4, 2024 04:01PM
Jun 5, 2024 07:00AM
Dec 19, 2023 04:16PM Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
Dec 15, 2023 03:37AM
Dec 14, 2023 11:07PM
Dec 14, 2023 04:00PM
Dec 14, 2023 04:00PM
May 24, 2023 07:00AM
Dec 14, 2022 04:05PM
Dec 7, 2022 06:20AM Syndax Pharmaceuticals (SNDX) Prices 6.82M Share Offering at $22
Dec 6, 2022 09:38PM
Dec 6, 2022 04:31PM
Dec 6, 2022 04:30PM
May 26, 2022 07:00AM
Feb 14, 2022 04:32PM
Dec 20, 2021 04:05PM
Dec 16, 2021 06:00AM Syndax Pharmaceuticals (SNDX) Prices 4.3M Share and Warrant Offering at $17.50/sh
Dec 15, 2021 11:37PM
Dec 15, 2021 04:30PM
Dec 15, 2021 04:29PM
Oct 25, 2021 08:00AM
Sep 27, 2021 06:13AM
Sep 27, 2021 06:00AM
Jun 3, 2021 07:00AM Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference
Dec 11, 2020 04:30PM
Dec 9, 2020 06:31AM
Dec 9, 2020 06:30AM
Dec 7, 2020 04:32PM
Dec 7, 2020 04:31PM
Jul 7, 2020 07:03AM
Jul 7, 2020 07:00AM Syndax Pharmaceuticals Appoints Daphne Karydas as Chief Financial Officer
Jul 10, 2019 08:53AM
Jul 12, 2018 09:15AM
Feb 1, 2018 09:31AM

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All